Generics 108

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sitagliptin manufacturers

108 products found

Filters

108 products found

sitagliptin

Oral solution 50 mg/2 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Canada , United Kingdom , United States
Manufacturer #8593
It is a private R&D and business development organization established in the 2000s, specializing in the design and development of new pharmaceutical products worldwide. They have an average of 5-6 new developments per year, an average of 8-10 DCPs per year, more than 60 dossier updates in the last 10 years, they have more than 3 valid and approved patent applications, and approximately 140 MAs worldwide.

Manufacturer usually replies in 2 days

sitagliptin

Tablets, film coated 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Januvia®
Manufacturer #252

Manufacturer usually replies in 2 days

sitagliptin + metformin

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg, 50 mg + 500 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Janumet® / Glucophage®
Manufacturer #252

Manufacturer usually replies in 2 days

sitagliptin + metformin

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
DCP successful, RMS SE, VN production site
Manufacturer #422

A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

sitagliptin

Tablets, film coated 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

sitagliptin + metformin

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #519

Manufacturer usually replies in 6 days

sitagliptin + metformin

Tablets 50 mg + 500 mg, 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Libya, Saudi Arabia, South Korea
Unavailable markets
Saudi Arabia , Vietnam
Available for
Licensing with supply
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

sitagliptin

Tablets 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA, EU GMP, ANVISA, Libya, Saudi Arabia, South Korea
Unavailable markets
Saudi Arabia , Vietnam
Manufacturer #11907
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products for 20+ years. Key production lines include Rx, OTC, medical devices, and cosmetics. The company's production lines are EU GMP-compliant. The company owns branches in the EU, North America, and Africa.

Manufacturer usually replies in 8 days

sitagliptin + metformin

Tablets 50mg+850mg, 50mg+1000mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1250

Manufacturer usually replies in 7 days

sitagliptin

Tablets 25mg, 50mg, 100mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #1250

Manufacturer usually replies in 7 days

sitagliptin + metformin

Tablets 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Available for
Licensing with supply, Distribution only
Comments
Dossier availability date: Q4 2023
Manufacturer #1377
A pharmaceutical manufacturer based in the EU that has been active in 40+ countries selling its products in Europe, the Middle East, North America, Africa, and Asia for 200+ years. Key production lines are Rx, OTC, nutraceuticals, and medical devices. The company's production lines are GMP-compliant. Main dosage forms include solids, liquids, semi-solids, and sterile forms.

Manufacturer usually replies in 8 days

sitagliptin

Tablets, film coated 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Janovia® (MSD)
Manufacturer #10578

Manufacturer usually replies in 6 days

sitagliptin + losartan

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, ANVISA
Unavailable markets
Vietnam
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

sitagliptin

Tablets, film coated 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP, ANVISA
Manufacturer #313

A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, and Asia for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. Main therapeutic areas include the respiratory system, dermatology, and cardiovascular system. The company possesses several branches in LATAM

Manufacturer usually replies in 7 days

sitagliptin + metformin

Tablets 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Arab Emirates
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

sitagliptin

Tablets 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

sitagliptin + metformin

Tablets, film coated 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Available for
Licensing with supply
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

sitagliptin

Tablets, film coated 25 mg, 50 mg, 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Portugal , Vietnam
Manufacturer #437
A pharmaceutical manufacturer based in the EU that is active in 40+ countries selling its products in Europe, North America, LATAM, Africa, Middle East, and Asia for 40+ years. Main therapeutics areas include the nervous system, cardiometabolic, and women’s health. The company's production lines are GMP-compliant. The main dosage forms are solid, semi-solid, liquid, and suspension. The company owns branches in the EU, Africa, and LATAM.

Manufacturer usually replies in 10 days

sitagliptin + metformin

Tablets, sustained release (SR) 50 mg + 500 mg, 100 mg + 1000 mg, 100 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Saudi Arabia , United Arab Emirates , Vietnam
Comments
Dossier availability date: Q1 2024
Manufacturer #17047
A pharmaceutical manufacturer based in the EU that sells its products in Europe, the Middle East, CIS, LATAM, and Asia. Key production lines are pharmaceuticals, bio and nanopharmaceuticals, medical devices, and nutraceuticals. The main therapeutic area is oncology.

Manufacturer usually replies in 10 days

sitagliptin + metformin

Tablets 50 mg + 500 mg, 50 mg + 850 mg, 50 mg + 1000 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #10033
A pharmaceutical manufacturer based in Europe specializes in development and manufacturing for 10+ years. Key production lines are Rx, OTC, and nutraceuticals. The main therapy areas include the immune system, CNS, and cardiovascular system. The main dosage forms include solid oral and injectable.

Manufacturer usually replies in 11 days

Want to view all 108 products? Create your free account today!

Sitagliptin Manufacturers

Sitagliptin is a medication used to lower blood sugar in patients with type 2 diabetes. Type 2 diabetes is a condition wherein blood sugar levels are too high because the body can not produce or use insulin properly. Sitagliptin belongs to the dipeptidyl peptidase-4 inhibitors class of drugs. It works by boosting the quantity of certain natural chemicals in the body that helps to reduce blood sugar levels when they are too high. Type 1 diabetes is not treated with sitagliptin. People with diabetes and hyperglycemia can develop significant or life-threatening complications such as heart disease, strokes, kidney failure, nerve damage, and vision difficulties over time. Taking medicine, changing your lifestyle, and checking your blood sugar regularly can help you manage your diabetes and improve your overall health. This therapy may also lower your risk of heart attack, stroke, or even other diabetes-related issues such as kidney failure, loss of feeling, numb, chilly legs or feet; impaired sexual capability in men and women; eye problems, including alterations or loss of vision; or gum disease. Sitagliptin is available as a pill that must be swallowed. It's taken once a day, with or without food. Every day, around the same hour, take sitagliptin. Follow the label instructions carefully, and if there is anything you don't understand, talk to your doctor or pharmacy to explain it to you. Sitagliptin should be taken exactly as prescribed. Please do not take more or less of it or take it more frequently than your doctor has suggested. Sitagliptin aids in the management of elevated blood sugar levels, but it does not cure diabetes. Even if you feel fine, keep taking sitagliptin.

How does Sitagliptin work?

The inactivation of insulin receptor substrates like GLP-1 and GIP is slowed when DPP-4 is inhibited by sitagliptin. As part of glucose homeostasis, incretins are released daily and increased in response to meals. Reduced incretin inhibition increases insulin production and decreases glucagon release in a glucose-dependent manner. These effects result in an overall improvement in blood glucose control, as seen by lower glycosylated hemoglobin levels. Sitagliptin is mainly not digested, with 79 percent of the dosage excreted unaltered as the parent molecule in the urineLabel. The cytochrome p450(CYP)3A4 and, to a smaller extent, the cytochrome p450(CYP)2C8 enzymes control minor metabolic pathways. Sitagliptin is 87 percent orally accessible, and its kinetics are unaffected by whether it is taken with or without food. In 2 hours, sitagliptin reaches its maximal plasma concentration.

The Cost of Sitagliptin

An online search for the wholesale price for sale of Sitagliptin for distributors will reveal a wide range of costs. It will vary from store to store depending on your visit and the country of the wholesale market. It costs up to $10 for 10mg. The price of this medication is still lower in the developing world. Sitagliptin Hydrochloride suppliers, on the whole, are in favor of patient aid initiatives. This cost may differ among dealers. Its price may vary depending on the country of origin, wholesale costs incurred by manufacturing companies, supplier pricing, and similar factors.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Sitagliptin distributors offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance Sitagliptin suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Sitagliptin. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Sitagliptin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical product deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers Sitagliptin suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are onboarded on the platform. This allows us to screen Sitagliptin Manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.